|
|
Peng Lu, M.D., Ph.D., chief medical officer at Pharvaris, a clinical-stage company focused on bringing oral bradykinin B2-receptor antagonists to patients, provides her perspective on diversity and inclusion at Big Pharma, along with what currently is happening at this Netherlands-based startup.
|